Research Library

Federal marijuana legalization is on the horizon — and it’s time for the DEA to get behind the policy changes and move on to fighting more dangerous drugs, writes nonresident fellow Gary Hale.

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.

The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.

This October the U.S. and Mexico agreed on a new bilateral security program, but "unless the United States and Mexico pursue domestic structural reforms ... both nations risk backsliding to the failures of the drug wars," writes MGA student and Drug Policy guest contributor Sidney Phillips.

In 1980, the Mariel Boatlift brought not only tens of thousands of political refugees from Cuba to Florida, but a significant number of criminals, leading to soaring murder and crime rates in the U.S. With Mexico now planning the release of potentially thousands of federal prisoners, is history set to repeat itself?

An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.

The death of George Floyd has accelerated calls for police reform. Although decriminalizing drugs and the people who use them will not end police violence, it is part of the structural change needed to fix the problem, writes fellow Katharine Neill Harris.

The collective trauma of the Covid-19 pandemic may provide a clearer understanding of why people use drugs — to help us see it not as a moral failing or a brain malfunction, but as a fundamentally human response to negative life events. Read more at the Baker Institute Blog.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.